{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T18:38:45Z","timestamp":1793299125226,"version":"4.5.0"},"reference-count":102,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,12,3]],"date-time":"2024-12-03T00:00:00Z","timestamp":1733184000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,12,3]],"date-time":"2024-12-03T00:00:00Z","timestamp":1733184000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100005010","name":"Associazione Italiana per la Ricerca sul Cancro","doi-asserted-by":"publisher","award":["IG 23049"],"award-info":[{"award-number":["IG 23049"]}],"id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005010","name":"Associazione Italiana per la Ricerca sul Cancro","doi-asserted-by":"publisher","award":["IG 23060"],"award-info":[{"award-number":["IG 23060"]}],"id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003407","name":"Ministero dell&apos;Istruzione, dell&apos;Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","award":["MIUR-PRIN2017"],"award-info":[{"award-number":["MIUR-PRIN2017"]}],"id":[{"id":"10.13039\/501100003407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003407","name":"Ministero dell&apos;Istruzione, dell&apos;Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","award":["MIUR\/PRIN2020"],"award-info":[{"award-number":["MIUR\/PRIN2020"]}],"id":[{"id":"10.13039\/501100003407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","award":["5x1000 funds"],"award-info":[{"award-number":["5x1000 funds"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","award":["Ricerca Corrente"],"award-info":[{"award-number":["Ricerca Corrente"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","award":["RF-2016-02361540"],"award-info":[{"award-number":["RF-2016-02361540"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","award":["RF-2021-12373957"],"award-info":[{"award-number":["RF-2021-12373957"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-024-54246-6","type":"journal-article","created":{"date-parts":[[2024,12,3]],"date-time":"2024-12-03T10:02:09Z","timestamp":1733220129000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Loss of NUMB drives aggressive bladder cancer via a RHOA\/ROCK\/YAP signaling axis"],"prefix":"10.1038","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6247-5392","authenticated-orcid":false,"given":"F. A.","family":"Tucci","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6542-7898","authenticated-orcid":false,"given":"R.","family":"Pennisi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D. C.","family":"Rigiracciolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. G.","family":"Filippone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Bonfanti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Romeo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4263-3060","authenticated-orcid":false,"given":"S.","family":"Freddi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-7492-1563","authenticated-orcid":false,"given":"E.","family":"Guerrera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4363-6597","authenticated-orcid":false,"given":"C.","family":"Soriani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4236-7823","authenticated-orcid":false,"given":"S.","family":"Rodighiero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4359-3884","authenticated-orcid":false,"given":"R. H.","family":"Gunby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Jodice","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Sanguedolce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Renne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Fusco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2252-0950","authenticated-orcid":false,"given":"P. P.","family":"Di Fiore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Pruneri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Bertalot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Musi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Vago","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4443-1059","authenticated-orcid":false,"given":"D.","family":"Tosoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1764-3929","authenticated-orcid":false,"given":"S.","family":"Pece","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,12,3]]},"reference":[{"key":"54246_CR1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21654","volume":"71","author":"RL Siegel","year":"2021","unstructured":"Siegel, R. L., Miller, K. D., Fuchs, H. E. & Jemal, A. Cancer Statistics, 2021. CA Cancer J. Clin. 71, 7\u201333 (2021).","journal-title":"CA Cancer J. Clin."},{"key":"54246_CR2","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/S0140-6736(09)60491-8","volume":"374","author":"DS Kaufman","year":"2009","unstructured":"Kaufman, D. S., Shipley, W. U. & Feldman, A. S. Bladder cancer. Lancet 374, 239\u2013249 (2009).","journal-title":"Lancet"},{"key":"54246_CR3","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1016\/j.cell.2018.07.036","volume":"174","author":"AG Robertson","year":"2018","unstructured":"Robertson, A. G. et al. Comprehensive molecular characterization of muscle-invasive bladder cancer. Cell 174, 1033 (2018).","journal-title":"Cell"},{"key":"54246_CR4","doi-asserted-by":"publisher","first-page":"2796","DOI":"10.1016\/S0140-6736(16)30512-8","volume":"388","author":"AM Kamat","year":"2016","unstructured":"Kamat, A. M. et al. Bladder cancer. Lancet 388, 2796\u20132810 (2016).","journal-title":"Lancet"},{"key":"54246_CR5","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.eururo.2020.03.055","volume":"79","author":"JA Witjes","year":"2021","unstructured":"Witjes, J. A. et al. European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2020 Guidelines. Eur. Urol. 79, 82\u2013104 (2021).","journal-title":"Eur. Urol."},{"key":"54246_CR6","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.annonc.2021.11.012","volume":"33","author":"T Powles","year":"2022","unstructured":"Powles, T. et al. Bladder cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up. Ann. Oncol. 33, 244\u2013258 (2022).","journal-title":"Ann. Oncol."},{"key":"54246_CR7","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.ccr.2004.08.002","volume":"6","author":"CP Dinney","year":"2004","unstructured":"Dinney, C. P. et al. Focus on bladder cancer. Cancer Cell 6, 111\u2013116 (2004).","journal-title":"Cancer Cell"},{"key":"54246_CR8","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/j.eururo.2011.05.045","volume":"60","author":"S van den Bosch","year":"2011","unstructured":"van den Bosch, S. & Alfred Witjes, J. Long-term cancer-specific survival in patients with high-risk, non-muscle-invasive bladder cancer and tumour progression: a systematic review. Eur. Urol. 60, 493\u2013500 (2011).","journal-title":"Eur. Urol."},{"key":"54246_CR9","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1016\/j.eururo.2003.10.006","volume":"45","author":"BP Schrier","year":"2004","unstructured":"Schrier, B. P., Hollander, M. P., van Rhijn, B. W., Kiemeney, L. A. & Witjes, J. A. Prognosis of muscle-invasive bladder cancer: difference between primary and progressive tumours and implications for therapy. Eur. Urol. 45, 292\u2013296 (2004).","journal-title":"Eur. Urol."},{"key":"54246_CR10","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.eururo.2016.05.041","volume":"71","author":"M Babjuk","year":"2017","unstructured":"Babjuk, M. et al. EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder: update 2016. Eur. Urol. 71, 447\u2013461 (2017).","journal-title":"Eur. Urol."},{"key":"54246_CR11","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.eururo.2014.01.006","volume":"66","author":"RS Svatek","year":"2014","unstructured":"Svatek, R. S. et al. The economics of bladder cancer: costs and considerations of caring for this disease. Eur. Urol. 66, 253\u2013262 (2014).","journal-title":"Eur. Urol."},{"key":"54246_CR12","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/j.urolonc.2010.04.003","volume":"28","author":"PJ Goebell","year":"2010","unstructured":"Goebell, P. J. & Knowles, M. A. Bladder cancer or bladder cancers? Genetically distinct malignant conditions of the urothelium. Urol. Oncol. 28, 409\u2013428 (2010).","journal-title":"Urol. Oncol."},{"key":"54246_CR13","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.ccell.2016.05.004","volume":"30","author":"J Hedegaard","year":"2016","unstructured":"Hedegaard, J. et al. Comprehensive transcriptional analysis of early-stage urothelial carcinoma. Cancer Cell 30, 27\u201342 (2016).","journal-title":"Cancer Cell"},{"key":"54246_CR14","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1016\/j.eururo.2017.05.032","volume":"72","author":"EJ Pietzak","year":"2017","unstructured":"Pietzak, E. J. et al. Next-generation sequencing of nonmuscle invasive bladder cancer reveals potential biomarkers and rational therapeutic targets. Eur. Urol. 72, 952\u2013959 (2017).","journal-title":"Eur. Urol."},{"key":"54246_CR15","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1038\/nrc1697","volume":"5","author":"XR Wu","year":"2005","unstructured":"Wu, X. R. Urothelial tumorigenesis: a tale of divergent pathways. Nat. Rev. Cancer 5, 713\u2013725 (2005).","journal-title":"Nat. Rev. Cancer"},{"key":"54246_CR16","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1038\/nature06412","volume":"451","author":"IN Colaluca","year":"2008","unstructured":"Colaluca, I. N. et al. NUMB controls p53 tumour suppressor activity. Nature 451, 76\u201380 (2008).","journal-title":"Nature"},{"key":"54246_CR17","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1111\/j.1440-1789.2008.00907.x","volume":"28","author":"B Yan","year":"2008","unstructured":"Yan, B. et al. Characterization of Numb expression in astrocytomas. Neuropathology 28, 479\u2013484 (2008).","journal-title":"Neuropathology"},{"key":"54246_CR18","doi-asserted-by":"publisher","first-page":"22293","DOI":"10.1073\/pnas.0907781106","volume":"106","author":"B Westhoff","year":"2009","unstructured":"Westhoff, B. et al. Alterations of the Notch pathway in lung cancer. Proc. Natl Acad. Sci. USA 106, 22293\u201322298 (2009).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"54246_CR19","first-page":"26","volume":"1815","author":"S Pece","year":"2011","unstructured":"Pece, S., Confalonieri, S., P, R. R. & Di Fiore, P. P. NUMB-ing down cancer by more than just a NOTCH. Biochim Biophys. Acta 1815, 26\u201343 (2011).","journal-title":"Biochim Biophys. Acta"},{"key":"54246_CR20","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1080\/15384047.2016.1276131","volume":"19","author":"Z Liu","year":"2018","unstructured":"Liu, Z. et al. Increased Numb protein expression predicts poor clinical outcomes in esophageal squamous cell carcinoma patients. Cancer Biol. Ther. 19, 34\u201341 (2018).","journal-title":"Cancer Biol. Ther."},{"key":"54246_CR21","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1083\/jcb.200406140","volume":"167","author":"S Pece","year":"2004","unstructured":"Pece, S. et al. Loss of negative regulation by Numb over Notch is relevant to human breast carcinogenesis. J. Cell Biol. 167, 215\u2013221 (2004).","journal-title":"J. Cell Biol."},{"key":"54246_CR22","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1083\/jcb.201709092","volume":"217","author":"IN Colaluca","year":"2018","unstructured":"Colaluca, I. N. et al. A Numb-Mdm2 fuzzy complex reveals an isoform-specific involvement of Numb in breast cancer. J. Cell Biol. 217, 745\u2013762 (2018).","journal-title":"J. Cell Biol."},{"key":"54246_CR23","doi-asserted-by":"publisher","unstructured":"Filippone, M. G. et al. Aberrant phosphorylation inactivates Numb in breast cancer causing expansion of the stem cell pool. J. Cell Biol. 221 https:\/\/doi.org\/10.1083\/jcb.202112001 (2022).","DOI":"10.1083\/jcb.202112001"},{"key":"54246_CR24","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-22465-w","volume":"12","author":"SV Lindskrog","year":"2021","unstructured":"Lindskrog, S. V. et al. An integrated multi-omics analysis identifies prognostic molecular subtypes of non-muscle-invasive bladder cancer. Nat. Commun. 12, 2301 (2021).","journal-title":"Nat. Commun."},{"key":"54246_CR25","doi-asserted-by":"publisher","first-page":"4040","DOI":"10.1158\/0008-5472.CAN-03-3620","volume":"64","author":"L Dyrskjot","year":"2004","unstructured":"Dyrskjot, L. et al. Gene expression in the urinary bladder: a common carcinoma in situ gene expression signature exists disregarding histopathological classification. Cancer Res 64, 4040\u20134048 (2004).","journal-title":"Cancer Res"},{"key":"54246_CR26","doi-asserted-by":"publisher","first-page":"4029","DOI":"10.1158\/1078-0432.CCR-04-2095","volume":"11","author":"L Dyrskjot","year":"2005","unstructured":"Dyrskjot, L. et al. A molecular signature in superficial bladder carcinoma predicts clinical outcome. Clin. Cancer Res 11, 4029\u20134036 (2005).","journal-title":"Clin. Cancer Res"},{"key":"54246_CR27","doi-asserted-by":"publisher","DOI":"10.1186\/1476-4598-9-3","volume":"9","author":"WJ Kim","year":"2010","unstructured":"Kim, W. J. et al. Predictive value of progression-related gene classifier in primary non-muscle invasive bladder cancer. Mol. Cancer 9, 3 (2010).","journal-title":"Mol. Cancer"},{"key":"54246_CR28","doi-asserted-by":"publisher","first-page":"478","DOI":"10.2119\/molmed.2010.00274","volume":"17","author":"WJ Kim","year":"2011","unstructured":"Kim, W. J. et al. A four-gene signature predicts disease progression in muscle invasive bladder cancer. Mol. Med 17, 478\u2013485 (2011).","journal-title":"Mol. Med"},{"key":"54246_CR29","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.ejca.2016.06.003","volume":"64","author":"AG van der Heijden","year":"2016","unstructured":"van der Heijden, A. G. et al. A five-gene expression signature to predict progression in T1G3 bladder cancer. Eur. J. Cancer 64, 127\u2013136 (2016).","journal-title":"Eur. J. Cancer"},{"key":"54246_CR30","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1093\/jnci\/djx243","volume":"110","author":"Q Mo","year":"2018","unstructured":"Mo, Q. et al. Prognostic power of a tumor differentiation gene signature for bladder urothelial carcinomas. J. Natl Cancer Inst. 110, 448\u2013459 (2018).","journal-title":"J. Natl Cancer Inst."},{"key":"54246_CR31","doi-asserted-by":"publisher","first-page":"856","DOI":"10.3389\/fonc.2019.00856","volume":"9","author":"M Abudurexiti","year":"2019","unstructured":"Abudurexiti, M. et al. Development and external validation of a novel 12-gene signature for prediction of overall survival in muscle-invasive bladder cancer. Front Oncol. 9, 856 (2019).","journal-title":"Front Oncol."},{"key":"54246_CR32","first-page":"379","volume":"43","author":"H Yin","year":"2020","unstructured":"Yin, H., Zhang, C., Gou, X., He, W. & Gan, D. Identification of a 13\u2011mRNA signature for predicting disease progression and prognosis in patients with bladder cancer. Oncol. Rep. 43, 379\u2013394 (2020).","journal-title":"Oncol. Rep."},{"key":"54246_CR33","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3389\/fgene.2020.00012","volume":"11","author":"H Qiu","year":"2020","unstructured":"Qiu, H. et al. Identification and validation of an individualized prognostic signature of bladder cancer based on seven immune related genes. Front Genet 11, 12 (2020).","journal-title":"Front Genet"},{"key":"54246_CR34","doi-asserted-by":"publisher","first-page":"5161","DOI":"10.1158\/0008-5472.CAN-21-1254","volume":"81","author":"S Park","year":"2021","unstructured":"Park, S. et al. Novel mouse models of bladder cancer identify a prognostic signature associated with risk of disease progression. Cancer Res 81, 5161\u20135175 (2021).","journal-title":"Cancer Res"},{"key":"54246_CR35","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2022.1057302","volume":"13","author":"Y Tao","year":"2022","unstructured":"Tao, Y. et al. TP53-related signature for predicting prognosis and tumor microenvironment characteristics in bladder cancer: A multi-omics study. Front Genet 13, 1057302 (2022).","journal-title":"Front Genet"},{"key":"54246_CR36","doi-asserted-by":"publisher","DOI":"10.1186\/s12894-022-00955-3","volume":"22","author":"F Tang","year":"2022","unstructured":"Tang, F. et al. A 7-gene signature predicts the prognosis of patients with bladder cancer. BMC Urol. 22, 8 (2022).","journal-title":"BMC Urol."},{"key":"54246_CR37","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/j.eururo.2024.01.001","volume":"85","author":"SK Kim","year":"2024","unstructured":"Kim, S. K. et al. A 23-gene prognostic index predicts progression and bacillus calmette-guerin response in non-muscle-invasive bladder cancer. Eur. Urol. 85, 400\u2013402 (2024).","journal-title":"Eur. Urol."},{"key":"54246_CR38","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-024-01945-9","volume":"23","author":"T Xie","year":"2024","unstructured":"Xie, T. et al. Multi-cohort validation of Ascore: an anoikis-based prognostic signature for predicting disease progression and immunotherapy response in bladder cancer. Mol. Cancer 23, 30 (2024).","journal-title":"Mol. Cancer"},{"key":"54246_CR39","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1016\/j.celrep.2018.10.001","volume":"25","author":"Y Wang","year":"2018","unstructured":"Wang, Y. et al. Comprehensive molecular characterization of the hippo signaling pathway in cancer. Cell Rep. 25, 1304\u20131317 e1305 (2018).","journal-title":"Cell Rep."},{"key":"54246_CR40","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1101\/gad.192856.112","volume":"26","author":"Y Liu-Chittenden","year":"2012","unstructured":"Liu-Chittenden, Y. et al. Genetic and pharmacological disruption of the TEAD-YAP complex suppresses the oncogenic activity of YAP. Genes Dev. 26, 1300\u20131305 (2012).","journal-title":"Genes Dev."},{"key":"54246_CR41","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-13-349","volume":"13","author":"JY Liu","year":"2013","unstructured":"Liu, J. Y. et al. Overexpression of YAP 1 contributes to progressive features and poor prognosis of human urothelial carcinoma of the bladder. BMC Cancer 13, 349 (2013).","journal-title":"BMC Cancer"},{"key":"54246_CR42","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-05939-2","volume":"9","author":"MK Gill","year":"2018","unstructured":"Gill, M. K. et al. A feed forward loop enforces YAP\/TAZ signaling during tumorigenesis. Nat. Commun. 9, 3510 (2018).","journal-title":"Nat. Commun."},{"key":"54246_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2022.104092","volume":"81","author":"SW Baek","year":"2022","unstructured":"Baek, S. W. et al. YAP1 activation is associated with the progression and response to immunotherapy of non-muscle invasive bladder cancer. EBioMedicine 81, 104092 (2022).","journal-title":"EBioMedicine"},{"key":"54246_CR44","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1016\/j.ccell.2016.05.005","volume":"29","author":"F Zanconato","year":"2016","unstructured":"Zanconato, F., Cordenonsi, M. & Piccolo, S. YAP\/TAZ at the Roots of Cancer. Cancer Cell 29, 783\u2013803 (2016).","journal-title":"Cancer Cell"},{"key":"54246_CR45","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1083\/jcb.201505037","volume":"211","author":"D Tosoni","year":"2015","unstructured":"Tosoni, D. et al. The Numb\/p53 circuitry couples replicative self-renewal and tumor suppression in mammary epithelial cells. J. Cell Biol. 211, 845\u2013862 (2015).","journal-title":"J. Cell Biol."},{"key":"54246_CR46","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-30375-8","volume":"13","author":"MG Filippone","year":"2022","unstructured":"Filippone, M. G. et al. CDK12 promotes tumorigenesis but induces vulnerability to therapies inhibiting folate one-carbon metabolism in breast cancer. Nat. Commun. 13, 2642 (2022).","journal-title":"Nat. Commun."},{"key":"54246_CR47","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1038\/ncb2956","volume":"16","author":"K Shin","year":"2014","unstructured":"Shin, K. et al. Cellular origin of bladder neoplasia and tissue dynamics of its progression to invasive carcinoma. Nat. Cell Biol. 16, 469\u2013478 (2014).","journal-title":"Nat. Cell Biol."},{"key":"54246_CR48","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1038\/ncb3038","volume":"16","author":"J Van Batavia","year":"2014","unstructured":"Van Batavia, J. et al. Bladder cancers arise from distinct urothelial sub-populations. Nat. Cell Biol. 16, 982\u2013991 (2014). 981-985.","journal-title":"Nat. Cell Biol."},{"key":"54246_CR49","first-page":"399","volume":"37","author":"M Nagao","year":"1977","unstructured":"Nagao, M., Suzuki, E., Yasuo, K., Yahagi, T. & Seino, Y. Mutagenicity of N-butyl-N-(4-hydroxybutyl)nitrosamine, a bladder carcinogen, and related compounds. Cancer Res 37, 399\u2013407 (1977).","journal-title":"Cancer Res"},{"key":"54246_CR50","doi-asserted-by":"publisher","first-page":"1911","DOI":"10.1038\/s41388-017-0099-6","volume":"37","author":"D Fantini","year":"2018","unstructured":"Fantini, D. et al. A Carcinogen-induced mouse model recapitulates the molecular alterations of human muscle invasive bladder cancer. Oncogene 37, 1911\u20131925 (2018).","journal-title":"Oncogene"},{"key":"54246_CR51","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/0014-2964(72)90137-5","volume":"8","author":"JS Bertram","year":"1972","unstructured":"Bertram, J. S. & Craig, A. W. Specific induction of bladder cancer in mice by butyl-(4-hydroxybutyl)-nitrosamine and the effects of hormonal modifications on the sex difference in response. Eur. J. Cancer (1965) 8, 587\u2013594 (1972).","journal-title":"Eur. J. Cancer (1965)"},{"key":"54246_CR52","doi-asserted-by":"publisher","first-page":"4567","DOI":"10.1073\/pnas.1803595116","volume":"116","author":"J Mullenders","year":"2019","unstructured":"Mullenders, J. et al. Mouse and human urothelial cancer organoids: A tool for bladder cancer research. Proc. Natl Acad. Sci. USA 116, 4567\u20134574 (2019).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"54246_CR53","doi-asserted-by":"publisher","unstructured":"Moriconi, C. et al. INSIDIA: A FIJI Macro Delivering High-Throughput and High-Content Spheroid Invasion Analysis. Biotechnol. J. 12 https:\/\/doi.org\/10.1002\/biot.201700140 (2017).","DOI":"10.1002\/biot.201700140"},{"key":"54246_CR54","doi-asserted-by":"publisher","first-page":"e0155901","DOI":"10.1371\/journal.pone.0155901","volume":"11","author":"S Alinezhad","year":"2016","unstructured":"Alinezhad, S. et al. Validation of Novel Biomarkers for Prostate Cancer Progression by the Combination of Bioinformatics, Clinical and Functional Studies. PLoS One 11, e0155901 (2016).","journal-title":"PLoS One"},{"key":"54246_CR55","doi-asserted-by":"publisher","first-page":"e96426","DOI":"10.1371\/journal.pone.0096426","volume":"9","author":"V Harma","year":"2014","unstructured":"Harma, V. et al. Quantification of dynamic morphological drug responses in 3D organotypic cell cultures by automated image analysis. PLoS One 9, e96426 (2014).","journal-title":"PLoS One"},{"key":"54246_CR56","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1152\/physrev.00005.2014","volume":"94","author":"S Piccolo","year":"2014","unstructured":"Piccolo, S., Dupont, S. & Cordenonsi, M. The biology of YAP\/TAZ: hippo signaling and beyond. Physiol. Rev. 94, 1287\u20131312 (2014).","journal-title":"Physiol. Rev."},{"key":"54246_CR57","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1038\/nrm.2017.87","volume":"18","author":"T Panciera","year":"2017","unstructured":"Panciera, T., Azzolin, L., Cordenonsi, M. & Piccolo, S. Mechanobiology of YAP and TAZ in physiology and disease. Nat. Rev. Mol. Cell Biol. 18, 758\u2013770 (2017).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"54246_CR58","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1038\/s41556-018-0142-z","volume":"20","author":"A Totaro","year":"2018","unstructured":"Totaro, A., Panciera, T. & Piccolo, S. YAP\/TAZ upstream signals and downstream responses. Nat. Cell Biol. 20, 888\u2013899 (2018).","journal-title":"Nat. Cell Biol."},{"key":"54246_CR59","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1038\/nature10137","volume":"474","author":"S Dupont","year":"2011","unstructured":"Dupont, S. et al. Role of YAP\/TAZ in mechanotransduction. Nature 474, 179\u2013183 (2011).","journal-title":"Nature"},{"key":"54246_CR60","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1101\/gad.274027.115","volume":"30","author":"Z Meng","year":"2016","unstructured":"Meng, Z., Moroishi, T. & Guan, K. L. Mechanisms of Hippo pathway regulation. Genes Dev. 30, 1\u201317 (2016).","journal-title":"Genes Dev."},{"key":"54246_CR61","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.yexcr.2015.10.034","volume":"343","author":"S Dupont","year":"2016","unstructured":"Dupont, S. Role of YAP\/TAZ in cell-matrix adhesion-mediated signalling and mechanotransduction. Exp. Cell Res 343, 42\u201353 (2016).","journal-title":"Exp. Cell Res"},{"key":"54246_CR62","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1016\/j.cell.2012.06.037","volume":"150","author":"FX Yu","year":"2012","unstructured":"Yu, F. X. et al. Regulation of the Hippo-YAP pathway by G-protein-coupled receptor signaling. Cell 150, 780\u2013791 (2012).","journal-title":"Cell"},{"key":"54246_CR63","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1016\/j.cell.2013.07.042","volume":"154","author":"M Aragona","year":"2013","unstructured":"Aragona, M. et al. A mechanical checkpoint controls multicellular growth through YAP\/TAZ regulation by actin-processing factors. Cell 154, 1047\u20131059 (2013).","journal-title":"Cell"},{"key":"54246_CR64","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/j.yexcr.2010.12.005","volume":"317","author":"KM Lau","year":"2011","unstructured":"Lau, K. M. & McGlade, C. J. Numb is a negative regulator of HGF dependent cell scattering and Rac1 activation. Exp. Cell Res 317, 539\u2013551 (2011).","journal-title":"Exp. Cell Res"},{"key":"54246_CR65","doi-asserted-by":"publisher","first-page":"3161","DOI":"10.1083\/jcb.201802023","volume":"217","author":"M Zobel","year":"2018","unstructured":"Zobel, M. et al. A NUMB-EFA6B-ARF6 recycling route controls apically restricted cell protrusions and mesenchymal motility. J. Cell Biol. 217, 3161\u20133182 (2018).","journal-title":"J. Cell Biol."},{"key":"54246_CR66","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexcr.2021.113004","volume":"411","author":"Y Yang","year":"2022","unstructured":"Yang, Y. et al. Numb inhibits migration and promotes proliferation of colon cancer cells via RhoA\/ROCK signaling pathway repression. Exp. Cell Res 411, 113004 (2022).","journal-title":"Exp. Cell Res"},{"key":"54246_CR67","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1016\/j.cell.2011.06.010","volume":"145","author":"AJ Ridley","year":"2011","unstructured":"Ridley, A. J. Life at the leading edge. Cell 145, 1012\u20131022 (2011).","journal-title":"Cell"},{"key":"54246_CR68","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1126\/science.273.5272.245","volume":"273","author":"K Kimura","year":"1996","unstructured":"Kimura, K. et al. Regulation of myosin phosphatase by Rho and Rho-associated kinase (Rho-kinase). Science 273, 245\u2013248 (1996).","journal-title":"Science"},{"key":"54246_CR69","doi-asserted-by":"publisher","first-page":"12257","DOI":"10.1074\/jbc.272.19.12257","volume":"272","author":"Y Kureishi","year":"1997","unstructured":"Kureishi, Y. et al. Rho-associated kinase directly induces smooth muscle contraction through myosin light chain phosphorylation. J. Biol. Chem. 272, 12257\u201312260 (1997).","journal-title":"J. Biol. Chem."},{"key":"54246_CR70","first-page":"3630","volume":"46","author":"JR Masters","year":"1986","unstructured":"Masters, J. R. et al. Tissue culture model of transitional cell carcinoma: characterization of twenty-two human urothelial cell lines. Cancer Res 46, 3630\u20133636 (1986).","journal-title":"Cancer Res"},{"key":"54246_CR71","first-page":"547","volume":"19","author":"G Davies","year":"1999","unstructured":"Davies, G., Jiang, W. G. & Mason, M. D. Cell-cell adhesion molecules and their associated proteins in bladder cancer cells and their role in mitogen induced cell-cell dissociation and invasion. Anticancer Res 19, 547\u2013552 (1999).","journal-title":"Anticancer Res"},{"key":"54246_CR72","doi-asserted-by":"publisher","DOI":"10.1038\/srep38531","volume":"6","author":"JI Warrick","year":"2016","unstructured":"Warrick, J. I. et al. FOXA1, GATA3 and PPAR\u0263 cooperate to drive luminal subtype in bladder cancer: a molecular analysis of established human cell lines. Sci. Rep. 6, 38531 (2016).","journal-title":"Sci. Rep."},{"key":"54246_CR73","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1016\/j.cell.2009.11.007","volume":"139","author":"JP Thiery","year":"2009","unstructured":"Thiery, J. P., Acloque, H., Huang, R. Y. & Nieto, M. A. Epithelial-mesenchymal transitions in development and disease. Cell 139, 871\u2013890 (2009).","journal-title":"Cell"},{"key":"54246_CR74","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/s41580-018-0080-4","volume":"20","author":"A Dongre","year":"2019","unstructured":"Dongre, A. & Weinberg, R. A. New insights into the mechanisms of epithelial-mesenchymal transition and implications for cancer. Nat. Rev. Mol. Cell Biol. 20, 69\u201384 (2019).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"54246_CR75","doi-asserted-by":"publisher","DOI":"10.1186\/1476-4598-10-8","volume":"10","author":"I Haque","year":"2011","unstructured":"Haque, I. et al. Cyr61\/CCN1 signaling is critical for epithelial-mesenchymal transition and stemness and promotes pancreatic carcinogenesis. Mol. Cancer 10, 8 (2011).","journal-title":"Mol. Cancer"},{"key":"54246_CR76","first-page":"2164","volume":"126","author":"S Sonnylal","year":"2013","unstructured":"Sonnylal, S. et al. Connective tissue growth factor causes EMT-like cell fate changes in vivo and in vitro. J. Cell Sci. 126, 2164\u20132175 (2013).","journal-title":"J. Cell Sci."},{"key":"54246_CR77","doi-asserted-by":"publisher","first-page":"655","DOI":"10.15252\/emmm.201606940","volume":"9","author":"D Tosoni","year":"2017","unstructured":"Tosoni, D. et al. Pre-clinical validation of a selective anti-cancer stem cell therapy for Numb-deficient human breast cancers. EMBO Mol. Med 9, 655\u2013671 (2017).","journal-title":"EMBO Mol. Med"},{"key":"54246_CR78","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-021-04263-w","volume":"12","author":"Y Shu","year":"2021","unstructured":"Shu, Y. et al. Loss of Numb promotes hepatic progenitor expansion and intrahepatic cholangiocarcinoma by enhancing Notch signaling. Cell Death Dis. 12, 966 (2021).","journal-title":"Cell Death Dis."},{"key":"54246_CR79","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1038\/nrurol.2014.195","volume":"11","author":"VA Belle","year":"2014","unstructured":"Belle, V. A., McDermott, N., Meunier, A. & Marignol, L. NUMB inhibition of NOTCH signalling as a therapeutic target in prostate cancer. Nat. Rev. Urol. 11, 499\u2013507 (2014).","journal-title":"Nat. Rev. Urol."},{"key":"54246_CR80","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms11914","volume":"7","author":"G Papafotiou","year":"2016","unstructured":"Papafotiou, G. et al. KRT14 marks a subpopulation of bladder basal cells with pivotal role in regeneration and tumorigenesis. Nat. Commun. 7, 11914 (2016).","journal-title":"Nat. Commun."},{"key":"54246_CR81","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1038\/nrc3858","volume":"15","author":"T Kobayashi","year":"2015","unstructured":"Kobayashi, T., Owczarek, T. B., McKiernan, J. M. & Abate-Shen, C. Modelling bladder cancer in mice: opportunities and challenges. Nat. Rev. Cancer 15, 42\u201354 (2015).","journal-title":"Nat. Rev. Cancer"},{"key":"54246_CR82","doi-asserted-by":"publisher","first-page":"24266","DOI":"10.1074\/jbc.273.37.24266","volume":"273","author":"U Laufs","year":"1998","unstructured":"Laufs, U. & Liao, J. K. Post-transcriptional regulation of endothelial nitric oxide synthase mRNA stability by Rho GTPase. J. Biol. Chem. 273, 24266\u201324271 (1998).","journal-title":"J. Biol. Chem."},{"key":"54246_CR83","doi-asserted-by":"publisher","first-page":"2437","DOI":"10.1091\/mbc.8.12.2437","volume":"8","author":"H Fujihara","year":"1997","unstructured":"Fujihara, H. et al. Inhibition of RhoA translocation and calcium sensitization by in vivo ADP-ribosylation with the chimeric toxin DC3B. Mol. Biol. Cell 8, 2437\u20132447 (1997).","journal-title":"Mol. Biol. Cell"},{"key":"54246_CR84","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/0092-8674(92)90163-7","volume":"70","author":"AJ Ridley","year":"1992","unstructured":"Ridley, A. J. & Hall, A. The small GTP-binding protein rho regulates the assembly of focal adhesions and actin stress fibers in response to growth factors. Cell 70, 389\u2013399 (1992).","journal-title":"Cell"},{"key":"54246_CR85","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1101\/gad.173435.111","volume":"26","author":"B Zhao","year":"2012","unstructured":"Zhao, B. et al. Cell detachment activates the Hippo pathway via cytoskeleton reorganization to induce anoikis. Genes Dev. 26, 54\u201368 (2012).","journal-title":"Genes Dev."},{"key":"54246_CR86","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1016\/j.ccr.2014.04.016","volume":"25","author":"X Feng","year":"2014","unstructured":"Feng, X. et al. Hippo-independent activation of YAP by the GNAQ uveal melanoma oncogene through a trio-regulated rho GTPase signaling circuitry. Cancer Cell 25, 831\u2013845 (2014).","journal-title":"Cancer Cell"},{"key":"54246_CR87","doi-asserted-by":"publisher","first-page":"2000","DOI":"10.1111\/j.1742-4658.2006.05216.x","volume":"273","author":"M Ernkvist","year":"2006","unstructured":"Ernkvist, M. et al. p130-angiomotin associates to actin and controls endothelial cell shape. FEBS J. 273, 2000\u20132011 (2006).","journal-title":"FEBS J."},{"key":"54246_CR88","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1002\/cm.20405","volume":"66","author":"V Gagne","year":"2009","unstructured":"Gagne, V. et al. Human angiomotin-like 1 associates with an angiomotin protein complex through its coiled-coil domain and induces the remodeling of the actin cytoskeleton. Cell Motil. Cytoskeleton 66, 754\u2013768 (2009).","journal-title":"Cell Motil. Cytoskeleton"},{"key":"54246_CR89","doi-asserted-by":"publisher","first-page":"1676","DOI":"10.1091\/mbc.e13-11-0701","volume":"25","author":"S Mana-Capelli","year":"2014","unstructured":"Mana-Capelli, S., Paramasivam, M., Dutta, S. & McCollum, D. Angiomotins link F-actin architecture to Hippo pathway signaling. Mol. Biol. Cell 25, 1676\u20131685 (2014).","journal-title":"Mol. Biol. Cell"},{"key":"54246_CR90","doi-asserted-by":"publisher","first-page":"6380","DOI":"10.1128\/MCB.00116-09","volume":"29","author":"RM Densham","year":"2009","unstructured":"Densham, R. M. et al. MST kinases monitor actin cytoskeletal integrity and signal via c-Jun N-terminal kinase stress-activated kinase to regulate p21Waf1\/Cip1 stability. Mol. Cell Biol. 29, 6380\u20136390 (2009).","journal-title":"Mol. Cell Biol."},{"key":"54246_CR91","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1038\/nrm4012","volume":"16","author":"M Murrell","year":"2015","unstructured":"Murrell, M., Oakes, P. W., Lenz, M. & Gardel, M. L. Forcing cells into shape: the mechanics of actomyosin contractility. Nat. Rev. Mol. Cell Biol. 16, 486\u2013498 (2015).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"54246_CR92","doi-asserted-by":"publisher","unstructured":"Su, D. et al. SPTAN1\/NUMB axis senses cell density to restrain cell growth and oncogenesis through Hippo signaling. J. Clin. Invest. 133 https:\/\/doi.org\/10.1172\/JCI168888 (2023).","DOI":"10.1172\/JCI168888"},{"key":"54246_CR93","doi-asserted-by":"publisher","first-page":"1698","DOI":"10.1038\/bjc.2014.95","volume":"110","author":"MT Huggett","year":"2014","unstructured":"Huggett, M. T. et al. Phase I\/II study of verteporfin photodynamic therapy in locally advanced pancreatic cancer. Br. J. Cancer 110, 1698\u20131704 (2014).","journal-title":"Br. J. Cancer"},{"key":"54246_CR94","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1188087","volume":"14","author":"SM Banerjee","year":"2023","unstructured":"Banerjee, S. M. et al. Combination of verteporfin-photodynamic therapy with 5-aza-2\u2019-deoxycytidine enhances the anti-tumour immune response in triple negative breast cancer. Front Immunol. 14, 1188087 (2023).","journal-title":"Front Immunol."},{"key":"54246_CR95","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.trecan.2022.12.001","volume":"9","author":"J Barcelo","year":"2023","unstructured":"Barcelo, J., Samain, R. & Sanz-Moreno, V. Preclinical to clinical utility of ROCK inhibitors in cancer. Trends Cancer 9, 250\u2013263 (2023).","journal-title":"Trends Cancer"},{"key":"54246_CR96","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1016\/S0960-9822(01)00149-X","volume":"11","author":"O Zilian","year":"2001","unstructured":"Zilian, O. et al. Multiple roles of mouse Numb in tuning developmental cell fates. Curr. Biol. 11, 494\u2013501 (2001).","journal-title":"Curr. Biol."},{"key":"54246_CR97","doi-asserted-by":"publisher","first-page":"6746","DOI":"10.4049\/jimmunol.178.11.6746","volume":"178","author":"A Wilson","year":"2007","unstructured":"Wilson, A. et al. Normal hemopoiesis and lymphopoiesis in the combined absence of numb and numblike. J. Immunol. 178, 6746\u20136751 (2007).","journal-title":"J. Immunol."},{"key":"54246_CR98","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1002\/gene.20025","volume":"39","author":"A Ramirez","year":"2004","unstructured":"Ramirez, A. et al. A keratin K5Cre transgenic line appropriate for tissue-specific or generalized Cre-mediated recombination. Genesis 39, 52\u201357 (2004).","journal-title":"Genesis"},{"key":"54246_CR99","doi-asserted-by":"publisher","first-page":"3772","DOI":"10.1200\/JCO.22.02762","volume":"41","author":"JP Stein","year":"2023","unstructured":"Stein, J. P. et al. Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients. J. Clin. Oncol. 41, 3772\u20133781 (2023).","journal-title":"J. Clin. Oncol."},{"key":"54246_CR100","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1038\/nmeth.2019","volume":"9","author":"J Schindelin","year":"2012","unstructured":"Schindelin, J. et al. Fiji: an open-source platform for biological-image analysis. Nat. Methods 9, 676\u2013682 (2012).","journal-title":"Nat. Methods"},{"key":"54246_CR101","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-17204-5","volume":"7","author":"P Bankhead","year":"2017","unstructured":"Bankhead, P. et al. QuPath: Open source software for digital pathology image analysis. Sci. Rep. 7, 16878 (2017).","journal-title":"Sci. Rep."},{"key":"54246_CR102","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.cels.2015.12.004","volume":"1","author":"A Liberzon","year":"2015","unstructured":"Liberzon, A. et al. The Molecular Signatures Database (MSigDB) hallmark gene set collection. Cell Syst. 1, 417\u2013425 (2015).","journal-title":"Cell Syst."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-54246-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-54246-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-54246-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,3]],"date-time":"2024-12-03T11:04:05Z","timestamp":1733223845000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-54246-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,3]]},"references-count":102,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["54246"],"URL":"https:\/\/doi.org\/10.1038\/s41467-024-54246-6","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,3]]},"assertion":[{"value":"9 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 December 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"G. Renne, G. Vago, D. Tosoni and S. Pece are co-inventors of a patent (EP24191940.6) related to this work, pending to the European Institute of Oncology and University of Milan. All the other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"10378"}}